新型冠状病毒抗原快速检测研发现状及展望*

新型冠状病毒肺炎疫情的全球大流行,对全球公共健康、社会和经济运转造成了重大影响。在药物研发迟滞及疫苗有效性未得到充分验证的情况下,对人群进行大规模的快速筛查,寻找潜在的感染者(尤其是轻症和无症状患者),并进行集中隔离,切断传播途径和保护易感人群是首要的任务。因此对于SARS-CoV-2感染,早期诊断尤为重要。总结现有市场上的新冠病毒抗原快速检测产品,对全球抗原快速检测市场进行分析,概述其研发的动向并展望了我国在新冠抗原检测新方法、新技术方面的自主创新能力。

The Development of Antigen Testing for SARS-CoV-2

The global pandemic of COVID-19 has taken a major impact on global public health, and social and economic operations. In the case of delays in drug development and insufficient verification of vaccine effectiveness, the priority is to take a large-scale rapid screening to filter out potential infections (especially mild and asymptomatic patients), isolate those infected patients centralized to cut off transmission routes and to protect the susceptible people. Therefore, early diagnosis of SARS-CoV-2 infection is particularly important. This paper summarizes the rapid detection products toward SARS-CoV-2 antigens in the current market, analyzes the global market of rapid SARS-CoV-2 antigen detection, outlines its research and development trends, and in the end discusses the prospects for developing the capability of independent innovation in new technologies and methods for SARS-CoV-2 antigen detection in our country.